Liliana Galicia-Rodríguez

Institutional and familial cost of patients in continuous ambulatory peritoneal dialysis

OBJECTIVE to determine the cost of institutional and familial care for patients with chronic kidney disease replacement therapy with continuous ambulatory peritoneal dialysis. METHODS a study of the cost of care for patients with chronic kidney disease treated with continuous ambulatory peritoneal dialysis was undertaken. The sample size (151) was calculated with the formula of the averages for an infinite population. The institutional cost included the cost of outpatient consultation, emergencies, hospitalization, ambulance, pharmacy, medication, laboratory, x-rays and application of erythropoietin. The family cost included transportation cost for services, cost of food during care, as well as the cost of medication and treatment materials acquired by the family for home care. The analysis included averages, percentages and confidence intervals. RESULTS the average annual institutional cost is US

Costo institucional del paciente con incapacidad temporal para el trabajo por lumbalgia mecánica

11,004.3. The average annual family cost is US

Costo directo de la atención médica en pacientes con gonartrosis

2,831.04. The average annual cost of patient care in continuous ambulatory peritoneal dialysis including institutional and family cost is US

Costo del proceso diagnóstico del cáncer de mama en las Unidades de Medicina Familiar del Instituto Mexicano del Seguro Social, Querétaro, México

13,835.35. CONCLUSION the cost of chronic kidney disease requires a large amount of economic resources, and is becoming a serious problem for health services and families. Its also true that the form of patient management in continuous ambulatory peritoneal dialysis is the most efficient in the use of institutional resources and family.

Coste-efectividad de la atención del paciente con diabetes mellitus tipo 2 manejado por el médico familiar versus estrategia educativa

Background Back pain affects frequently to the economically active people. it is the first cause of business day loss in workers aged 55 or less, and the second cause of absenteeism. Objective To determine the institutional cost of the patient with temporary inability to work, due to low back pain. Methods Costs design records of patients <55 years old, with temporary inability to work were analyzed. The sample size (228 patients) was calculated with the average formula for infinite people, with confidence interval of 95%. The sample technique was by quota, using the listing of patients with temporary inability to work and mechanical low back pain, as framework. Variables used were socio-demographic characteristics, unit cost and average cost of services provided. Statistical analysis included percentages, means, confidence interval and projection. Results Total average cost of the patient with mechanical low back pain is about 1,744.08 uSD, the inability represents the highest average cost (1,083.71 uSD), followed by cabinet studies (394.89 uSD), appointments (180.52 uSD), medications and laboratory. Conclusion The institutional cost of the patient with inability to work secondary to low back pain is high and the cost increases to millions in a population of patients.

Control de los pacientes con diabetes tratados sólo con esquema farmacológico

OBJECTIVE To determine the cost of medical care in patients with gonarthrosis. MATERIAL AND METHODS Cost study in patients over 40 years of age with gonarthrosis, diagnosed according to the radiological classification of Kellgren and Lawrence. The average annual cost (euros) was estimated taking the unit cost plus average use of services such as family medicine, imaging, laboratory, electrodiagnosis, orthopedics, hospitalization, physical therapy, surgery, nutrition, preoperative assessment and medication. Projections based on assumptions were made for three scenarios. RESULTS Grade 2 gonarthrosis predominated at 39.7% (95% confidence interval, 33.8 - 45.6). The annual cost of care for a patient with gonarthrosis was €108.87 in the intermediate scenario, €86.73 in the lower cost scenario and €132.60 in the higher cost scenario. For a population of 119,530,753 inhabitants, with 10,937,064 gonarthrosis patients, the annual cost in the intermediate scenario was €1,190,685,273 and represented 4.48% of the health expenditure. CONCLUSION The average annual cost of gonarthrosis is relatively low, but when related to prevalence and prevalence trends, it can become a serious problem for health services.

Economic cost of polypharmacy in the elderly in primary health care

Objetivo: Determinar el costo del proceso diagnostico del cancer de mama. Metodos: Estudio de costos, en mujeres de 40 anos y mas, de enero a diciembre del 2010 de las unidades de medicina familiar del Instituto Mexicano del Seguro Social. La muestra se calculo con la formula de promedios para poblacion infinita para un total de 245 mujeres. El costo se estimo mediante la tecnica de tiempos y movimientos y consulta de expertos; el costo por uso de intervencion se calculo con el uso promedio por intervencion multiplicado por el costo unitario del mismo. El costo total del proceso diagnostico se obtuvo de la suma de los costos de cada uno de las intervenciones. El plan de analisis incluyo promedios, porcentajes e intervalos de confianza. Resultados: El costo promedio del proceso diagnostico fue de

Estrategia de afrontamiento de la diabetes como factor de riesgo para el estilo de vida

852,45. Conclusion: El proceso diagnostico de cancer de mama incluye tamizaje y casos confirmados. El costo del proceso diagnostico es relativamente bajo ofreciendo mejores perspectivas para el paciente y el sistema de salud.

Relación entre apoyo social funcional y satisfacción vital del adulto mayor jubilado

Cost effectiveness of type 2 Diabetes Mellitus patient care handled by family doctor versus educational strategy.